- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/00 - General protective or antinoxious agents
Patent holdings for IPC class A61P 39/00
Total number of patents in this class: 1006
10-year publication summary
|
32
|
33
|
54
|
60
|
55
|
87
|
69
|
92
|
103
|
59
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9289 |
17 |
| The Regents of the University of California | 19961 |
10 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3166 |
9 |
| DSM IP Assets B.V. | 5585 |
8 |
| Board of Regents, The University of Texas System | 5808 |
8 |
| Peking University | 1313 |
7 |
| Janssen Pharmaceutica N.V. | 3394 |
6 |
| Orthogen AG | 54 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
5 |
| The Trustees of the University of Pennsylvania | 4323 |
5 |
| Aldeyra Therapeutics, Inc. | 109 |
5 |
| Baylor College of Medicine | 950 |
5 |
| The Board of Regents of the University of Oklahoma | 616 |
5 |
| Epicentrx, Inc. | 90 |
5 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 370 |
5 |
| Ikaria, Inc. | 12 |
5 |
| MedImmune Limited | 617 |
5 |
| Teva Pharmaceuticals Australia Pty Ltd | 30 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2855 |
5 |
| Centre National de La Recherche Scientifique | 10464 |
4 |
| Other owners | 876 |